Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The Potential of the Flavonoid Content of Ipomoea batatas L. as an Alternative Analog GLP-1 for Diabetes Type 2 Treatment-Systematic Review.
Metabolites. 2023 Dec 31;14(1):29. doi: 10.3390/metabo14010029.
Metabolites. 2023.
PMID: 38248832
Free PMC article.
Review.
The search query was based on specific keywords, including Ipomoea batatas OR sweet potato AND anti-diabetic OR hypoglycemic. ...The intracellular L cells effectively retain Ca(2+), leading to the subsequent release of GLP-1. Flavonols, flavones, and f …
The search query was based on specific keywords, including Ipomoea batatas OR sweet potato AND anti-diabetic OR hypoglycemic. …
New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study.
Almasri IM, Taha MO, Mohammad MK.
Almasri IM, et al.
Arch Pharm Res. 2013 Nov;36(11):1326-37. doi: 10.1007/s12272-013-0224-1. Epub 2013 Aug 6.
Arch Pharm Res. 2013.
PMID: 23918649
DPP IV inhibitors improve glycemic control by preventing the rapid inactivation of the incretin hormones; glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide. ...Subsequently, the optimum validated pharmacophore m …
DPP IV inhibitors improve glycemic control by preventing the rapid inactivation of the incretin hormones; glucagon-like pep …
Item in Clipboard
Cite
Cite